Search

Author/Creator Bradley, Chris

1. 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial. Issue 10191 (29th June 2019)

Authors:
Earl, Helena M; Hiller, Louise; Vallier, Anne-Laure; Loi, Shrushma; McAdam, Karen; Hughes-Davies, Luke; Harnett, Adrian N; Ah-See, Mei-Lin; Simcock, Richard; Rea, Daniel; Raj, Sanjay; Woodings, Pamela; Harries, Mark; Howe, Donna; Raynes, Kerry; Higgins, Helen B; Wilcox, Maggie; Plummer, Chris; Ma...
Journal:
Lancet
Issue:
Volume 393:Issue 10191(2019)
Page Start:
2599
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Developments in water quality monitoring and management in large river catchments using the Danube River as an example. Issue 64 (October 2016)

Authors:
Chapman, Deborah V.; Bradley, Chris; Gettel, Gretchen M.; Hatvani, István Gábor; Hein, Thomas; Kovács, József; Liska, Igor; Oliver, David M.; Tanos, Péter; Trásy, Balázs; Várbíró, Gábor
Journal:
Environmental science & policy
Issue:
Issue 64(2016:Oct.)
Page Start:
141
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Developments in water quality monitoring and management in large river catchments using the Danube River as an example. Issue 64 (October 2016)

Authors:
Chapman, Deborah V.; Bradley, Chris; Gettel, Gretchen M.; Hatvani, István Gábor; Hein, Thomas; Kovács, József; Liska, Igor; Oliver, David M.; Tanos, Péter; Trásy, Balázs; Várbíró, Gábor
Journal:
Environmental science & policy
Issue:
Issue 64(2016:Oct.)
Page Start:
141
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗